PLATINO E VP16 - 213 NEL CARCINOMA OVARICO (BULKY DISEASE) RESISTENTE ALL'ASSOCIAZIONE ADRIAMICINA - CICLOFOSFAMIDE

Translated title of the contribution: Cisplatin plus VP16-213 as second line treatment in ovarian cancer bulky disease, resistant to adriamycin plus cyclophosphamide

M. De Lena, V. Lorusso, A. De Leonardis

Research output: Contribution to journalArticle

Translated title of the contributionCisplatin plus VP16-213 as second line treatment in ovarian cancer bulky disease, resistant to adriamycin plus cyclophosphamide
Original languageItalian
Pages (from-to)102-112
Number of pages11
JournalFolia Oncologica
Volume7
Issue number2
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Oncology

Cite this